Carbetocin Impurity 4

Carbetocin Impurity 4 is a peptide-related compound structurally associated with carbetocin, a synthetic analog of oxytocin. As an impurity reference standard, it holds significant value in the context of peptide synthesis, analytical characterization, and pharmaceutical research. Its unique structural features and close relationship to the parent molecule make it an essential tool for quality control, method development, and the elucidation of degradation pathways in peptide-based drug manufacturing. Researchers and analysts utilize such impurities to ensure the integrity, safety, and efficacy of peptide therapeutics by accurately identifying and quantifying potential by-products formed during synthesis or storage.

Analytical method development: Carbetocin Impurity 4 is widely employed in the development and validation of chromatographic and spectrometric methods for the detection and quantification of process-related impurities in peptide drug substances. Its defined chemical identity enables laboratories to establish robust analytical protocols, assess method specificity, and determine the sensitivity of impurity detection. This is particularly important for regulatory submissions and routine quality assurance, where precise impurity profiling is required to meet stringent industry standards.

Reference standard for quality control: In manufacturing settings, the impurity serves as a critical reference material for the routine quality control of carbetocin bulk substances and finished products. By providing a known benchmark, it allows for the accurate calibration of analytical instruments and the verification of impurity limits within production batches. This ensures that the final pharmaceutical product maintains consistent quality and meets established safety criteria, minimizing the risk of unrecognized contaminants.

Peptide degradation studies: The presence of Carbetocin Impurity 4 facilitates in-depth studies on the stability and degradation pathways of carbetocin and related peptides. Researchers use this impurity to simulate and monitor degradation under various stress conditions, such as exposure to heat, light, or differing pH levels. Understanding the formation and behavior of such impurities aids in optimizing formulation strategies, packaging solutions, and storage conditions to enhance the shelf-life and reliability of peptide therapeutics.

Process optimization in peptide synthesis: During the synthesis of carbetocin and similar peptides, the formation of related impurities like Impurity 4 is closely monitored to evaluate and improve synthetic protocols. By tracking the occurrence and levels of this impurity at different stages, chemists can refine reaction conditions, purification steps, and reagent selection. This iterative optimization not only increases overall yield and purity but also reduces manufacturing costs and environmental impact by minimizing unwanted by-product formation.

Regulatory documentation and compliance: Carbetocin Impurity 4 plays a vital role in compiling comprehensive impurity profiles required for regulatory filings and product dossiers. Its inclusion in documentation supports transparent reporting of process-related impurities, enabling regulatory authorities to assess product safety and manufacturing consistency. Accurate identification and quantification of such impurities are fundamental to meeting international guidelines for peptide drug approval and ongoing market surveillance.

1. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

3. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

4. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes